Yarbrough Capital LLC purchased a new stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 16,113 shares of the company's stock, valued at approximately $329,000.
A number of other large investors have also added to or reduced their stakes in the business. TimesSquare Capital Management LLC boosted its holdings in shares of Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company's stock worth $71,657,000 after buying an additional 1,756,100 shares during the period. Artisan Partners Limited Partnership lifted its holdings in Stevanato Group by 28.7% during the 4th quarter. Artisan Partners Limited Partnership now owns 2,355,799 shares of the company's stock worth $51,333,000 after purchasing an additional 524,989 shares during the last quarter. Bamco Inc. NY lifted its holdings in Stevanato Group by 7.9% during the 4th quarter. Bamco Inc. NY now owns 1,818,181 shares of the company's stock worth $39,618,000 after purchasing an additional 133,000 shares during the last quarter. Teacher Retirement System of Texas increased its position in Stevanato Group by 56.3% during the fourth quarter. Teacher Retirement System of Texas now owns 1,250,000 shares of the company's stock worth $27,238,000 after acquiring an additional 450,000 shares during the period. Finally, Thornburg Investment Management Inc. increased its position in Stevanato Group by 48.1% during the fourth quarter. Thornburg Investment Management Inc. now owns 1,122,098 shares of the company's stock worth $24,451,000 after acquiring an additional 364,471 shares during the period.
Stevanato Group Stock Up 0.5%
Stevanato Group stock traded up €0.13 ($0.15) during midday trading on Wednesday, reaching €24.77 ($28.47). The stock had a trading volume of 399,990 shares, compared to its average volume of 335,576. Stevanato Group S.p.A. has a 12 month low of €16.56 ($19.03) and a 12 month high of €25.75 ($29.60). The company has a market capitalization of $7.50 billion, a P/E ratio of 52.70, a PEG ratio of 7.18 and a beta of 0.53. The company has a fifty day moving average price of €22.13 and a two-hundred day moving average price of €21.54. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22.
Stevanato Group Increases Dividend
The business also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be given a $0.0613 dividend. This is a positive change from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date of this dividend is Thursday, June 5th. This represents a yield of 0.3%. Stevanato Group's payout ratio is currently 11.76%.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on STVN. Stephens raised Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Finally, UBS Group cut their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research report on Friday, March 7th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Stevanato Group has a consensus rating of "Moderate Buy" and an average price target of €25.70 ($29.54).
Read Our Latest Research Report on Stevanato Group
About Stevanato Group
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Further Reading
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
